Yaral Pharma launches diclofenac epolamine topical system 1.3%
Diclofenac epolamine topical system 1.3% offers patients a non-opioid topical treatment
Diclofenac epolamine topical system 1.3% offers patients a non-opioid topical treatment
To create leading company developing medicines targeting metalloenzymes
Krishna Institute of Medical Sciences to consider raising Rs. 300 crores
The company continue to develop this program for the WHO markets, thereby providing coverage and protection for more infants globally in time to come
The newly built centre will work as the state-of-the-art facility for not just ethical animal studies but spans from basic, applied to regulatory animal research.
India now has 648 medical colleges in 2022 with a whopping 96% increase in the number of Government Medical Colleges (GMC) alone and a 42% increase in the private sector, since 2014
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
The company will submit an action plan on the observations and will engage with US FDA for next steps.
The MOU will involve product collaboration from both companies with a goal of propelling PFAS destruction in groundwater globally
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
Subscribe To Our Newsletter & Stay Updated